Impact of heteroresistance on treatment outcomes of people with drug-resistant TB.
Crowder R, Kato-Maeda M, Schwem B, Dela Tonga A, Geocaniga-Gaviola DM, Lopez E, Valdez CL, Lim AR, Hunat N, Sedusta AG, Sacopon CA, Atienza GAM, Bulag E, Lim D, Bascuña J, Shah K, Basillio RP, Berger CA, Lopez MCDP, Sen S, Allender C, Folkerts M, Karaoz U, Brodie E, Mitarai S, Garfin AMC, Ama MC, Engelthaler DM, Cattamanchi A, Destura R.
Crowder R, et al. Among authors: engelthaler dm.
IJTLD Open. 2024 Oct 1;1(10):466-472. doi: 10.5588/ijtldopen.24.0343. eCollection 2024 Oct.
IJTLD Open. 2024.
PMID: 39398438
Free PMC article.